Use of Very Low-Dose Naltrexone During Opiate Detoxification

References

• Pfab , R , Hirtl , C and Zilker , T . 1999 . Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure . J Toxicol Clin Toxicol , 37 : 43 – 50 .
   PubMed Web of Science ®Google Scholar
• Mannelli , P , De Risio , S Pozzi , G . 1999 . Serendipitous rapid detoxification from opiates: the importance of time-dependent processes . Addiction , 94 (4) : 589 – 591 .
   PubMed Web of Science ®Google Scholar
• Gonzalez , J P and Brogden , R N . 1988 . Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence . Drugs , 35 (3) : 192 – 213 .
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association . 1994 . Diagnostic and statistical manual of mental disorders, , 4th ed. , Washington, DC : American Psychiatric Press .
   Google Scholar
• Handelsman , L , Cochrane , K J Aronson , M J . 1987 . Two new rating scales for opiate withdrawal . Am J Drug Alcohol Abuse , 13 (3) : 293 – 308 .
   PubMed Web of Science ®Google Scholar
• Stine , S M and Kosten , T R . 1992 . Use of drug combinations in treatment of opioid withdrawal . J Clin Psychopharmacol , 12 : 203 – 209 .
   PubMed Web of Science ®Google Scholar
• Greeley , J D , Le , A D , Poulos , C X and Cappel , H . 1988 . “Paradoxical” analgesia induced by naloxone and naltrexone . Psychopharmacology , 96 (1) : 36 – 39 .
   Web of Science ®Google Scholar
• Crain , S M and Shen , K F . 2000 . Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability . Pain , 84 (2–3) : 121 – 131 .
   Google Scholar
• Levine , J D , Gordon , N C , Taiwo , Y O and Coderre , D J . 1988 . Potentiation of pentazocine analgesia by low-dose naloxone . J Clin Invest , 82 : 1574 – 1577 .
   PubMed Web of Science ®Google Scholar
• Jaffe , J H , Knapp , C M and Ciraulo , D A . 1997 . “ Opiates: clinical aspects ” . In Substance Abuse: a comprehensive textbook , Edited by: Lowinson , J H , Ruiz , P , Millman , R B and Langrod , J G . 158 – 166 . Baltimore, MD : William & Wilkins .
   Google Scholar
• Simon , D L . 1997 . Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art . J Addict Dis. , 16 : 103 – 122 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P G and Kosten , T R . 1998 . Rapid and ultrarapid opioid detoxification techniques . J Am Med Assoc , 279 (3) : 229 – 234 .
   PubMed Web of Science ®Google Scholar
• Goldstein , A . 1973 . Interactions of narcotic antagonists with receptor sites . Adv Biochem Psychopharmacol , 8 : 471 – 481 .
   PubMedGoogle Scholar
• Ueda , H , Fukushima , N , Kitao , T Ge , M . 1986 . Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephaline release . Neurosci Lett , 65 : 247 – 252 .
   PubMed Web of Science ®Google Scholar
• Crain , S M and Shen , K . 1995 . Ultralow concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment . Proc Natl Acad Sci. , 92 : 10540 – 10544 .
   PubMed Web of Science ®Google Scholar